BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4
Morita, K, Masamoto, Y, Kataoka, K, Koya, J, Kagoya, Y, Yashiroda, H, Sato, T, Murata, S, Kurokawa, M
Published in Leukemia (01.11.2015)
Published in Leukemia (01.11.2015)
Get full text
Journal Article
Evil defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Sato, T, Goyama, S, Kataoka, K, Nasu, R, Tsuruta-Kishino, T, Kagoya, Y, Nukina, A, Kumagai, K, Kubota, N, Nakagawa, M, Arai, S, Yoshimi, A, Honda, H, Kadowaki, T, Kurokawa, M
Published in Oncogene (16.10.2014)
Published in Oncogene (16.10.2014)
Get full text
Journal Article
Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Sato, T, Goyama, S, Kataoka, K, Nasu, R, Tsuruta-Kishino, T, Kagoya, Y, Nukina, A, Kumagai, K, Kubota, N, Nakagawa, M, Arai, S, Yoshimi, A, Honda, H, Kadowaki, T, Kurokawa, M
Published in Oncogene (16.10.2014)
Published in Oncogene (16.10.2014)
Get full text
Journal Article